Jul 05,2018

MetaOptima Technology raises $8.6 million CAD

MetaOptima Technology is pleased to announce that it has raised $8.6 million CAD ($6.5 million USD) to expand its advanced dermatology and skin cancer imaging and management software, DermEngine™, into global markets. This marks a key advancement in the way skin cancer is screened, detected, and managed. Funds will be used to implement and build its intelligent dermatology platform DermEngine into the global dermatology industry beginning with Australia. MetaOptima Technology is pleased to announce that it has raised $8.6 million CAD ($6.5 million USD) to expand its advanced dermatology and skin cancer imaging and management software, DermEngine™, into global markets. This marks a key advancement in the way skin cancer is screened, detected, and managed.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Apr 05,2018

Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline

Finnish digital health company Kaiku Health Oy, which provides intelligent patient monitoring software for healthcare providers across Europe, has closed a €4.4 million funding round. The investment was led by Debiopharm Innovation Fund SA and Tesi with participation from Prodeko Ventures Oy and existing investors Reaktor Ventures Oy, Metsola Ventures Oy, and Athensmed Oy.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Aug 23,2015

Skin Cancer Checker App, SkinVision, Snags $3.4M To Move Beyond Moles

Can an app warn you that you might have skin cancer? Digital health startup SkinVision is using smartphone tech and vision algorithms to allow consumers to track changes to their moles. SkinVision is now announcing what a terms a late Series A/early Series B funding round of €3 million ($3.4M), bringing its total raised to date to between €5 million and €6 million. Since the initial app launch, the business has grown into what Uyttewaal terms a “solutions platform”, monetizing its software via different monthly subscription pricing models — which vary depending on the country.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 28,2019

Digital health company developing minimally invasive CGM Biolinq raises additional $4.75M

This morning Biolinq, a digital health company specializing in minimally invasive continuous glucose monitoring, raised $4.75 million in extended Series A financing. This new capital was led by JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jul 16,2019

Smartphone-connected glucometer Pops! Diabetes Care rakes in $6M

Diabetes management startup Pops! Diabetes Care has scored $6 million in an oversubscribed Series A round. The round was led by 30Ventures with participation from Rise of the Rest Seed Fund and Flying Point Industries.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Sep 09,2019

DIAMONTECH SUCCESSFULLY COMPLETES A FINANCING ROUND OF OVER 7 MILLION EUROS

DiaMonTech GmbH, a young, innovative medical technology company, has successfully completed its Series A financing round. The company will receive a total of more than 7 million euros. The lead investor for this growth financing is Bioventure, an investor specializing in biotech and life sciences. In addition, DiaMonTech has gained two family offices as new investors. Existing shareholders - such as IBB Beteiligungsgesellschaft with the VC Fonds Technologie Berlin - also participated in the financing round.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jan 08,2018

Fitbit invests $6M in glucose monitoring startup Sano

Fitbit has recently invested $6 million in San Fransisco-based Sano, a company developing a mobile app and sensor that will allow users to continuously monitor blood glucose levels, multiple publications have confirmed.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Nov 27,2017

Minimally Invasive CGM company Biolinq raises $10 million in Series A funding

San Diego-based Biolinq, a digital health company specializing in minimally invasive continuous glucose monitoring, raised $10 million in Series A financing. The round was led by M Ventures, in collaboration with Hikma Ventures. Biolinq is currently working on a skin applied, minimally-invasive electrochemical biosensor platform for diabetes patients, which analyzes biomarkers in the interstitial fluid to provide actionable health information. The funding will enable the company to expand its team, and get its product through the clinical validation trials necessary for FDA approval.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Dec 20,2017

Biotech startup Nuritas raises €16 million in Series A funding

Nuritas, an Irish biotech startup, has raised €16 million in a Series A round led by US firm Cultivian Sandbox Ventures. Nuritas has built a medical platform that uses artificial intelligence to analyse peptides in food that can positively impact in conditions like pre-diabetes while reducing the cost and time needed to find them.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Apr 07,2016

OurCrowd & Philips Join to Raise $3.5 Million for Sweetch MedTech Startup

Sweetch Health, an Israeli medtech startup that has developed a “digital vaccine” for diabetes, has received series A funding in the amount of $3.5 million. The funding round was led by global conglomerate Philips and leading equity crowdfunding platform OurCrowd. The funding also saw participation from earlier investors including Lionbird and Pontifax. Sweetch’s behavioral analytics engine may also be applied to other significant chronic diseases and pre-chronic disease states, such as pre-hypertension and hypertension, obesity and metabolic syndrome.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES A